⌘K
Loading ticker…
Verrica Pharmaceuticals Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Verrica Pharmaceuticals Inc. Common Stock (VRCA) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.0%, relative volume 2.80×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 91, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
VRCA is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $719K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $719K |
| VTIVanguard Total Stock Market ETF | 0.00% | $279K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VRCA Jan avg: 5.57% median: -11.44% win: 25% σ: 42.09% n: 4 2022-04-12 → 2026-05-29 | VRCA Feb avg: 9.77% median: -3.25% win: 50% σ: 39.77% n: 4 2022-04-12 → 2026-05-29 | VRCA Mar avg: -9.74% median: -9.71% win: 25% σ: 18.79% n: 4 2022-04-12 → 2026-05-29 | VRCA Apr avg: 3.90% median: 4.98% win: 60% σ: 16.16% n: 5 2022-04-12 → 2026-05-29 | VRCA May avg: -11.92% median: -8.10% win: 40% σ: 35.25% n: 5 2022-04-12 → 2026-05-29 | VRCA Jun avg: -1.48% median: 0.62% win: 50% σ: 9.16% n: 4 2022-04-12 → 2026-05-29 (current) | VRCA Jul avg: 15.47% median: 3.71% win: 75% σ: 33.06% n: 4 2022-04-12 → 2026-05-29 | VRCA Aug avg: -15.65% median: -11.36% win: 25% σ: 37.62% n: 4 2022-04-12 → 2026-05-29 | VRCA Sep avg: -25.35% median: -24.24% win: 0% σ: 9.81% n: 4 2022-04-12 → 2026-05-29 | VRCA Oct avg: -9.92% median: -10.00% win: 0% σ: 6.49% n: 4 2022-04-12 → 2026-05-29 | VRCA Nov avg: 43.51% median: 15.26% win: 50% σ: 74.30% n: 4 2022-04-12 → 2026-05-29 | VRCA Dec avg: 7.38% median: -12.03% win: 25% σ: 63.06% n: 4 2022-04-12 → 2026-05-29 |